| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |